- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention2016 | Publication without faculty affiliation
- Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines: Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial2009 | Third Faculty of Medicine
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry2014 | Third Faculty of Medicine
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | Third Faculty of Medicine
- Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery2013 | Publication without faculty affiliation
- Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry2014 | Third Faculty of Medicine
- Strategy of antiaggregation treatment after percutaneous coronary interventions2012 | Third Faculty of Medicine
- Prasugrel2011 | Third Faculty of Medicine
- The Task Force on the use of antiplatelet in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology2004 | Faculty of Physical Education and Sport
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents2014 | Faculty of Medicine in Hradec Králové
- New antiplatelet drugs in therapy of cardiovascular diseases2009 | First Faculty of Medicine, Third Faculty of Medicine
- Pilot register of acute myocardial infarction - a 5-year evaluation of quality of care in non-PCI hospitals2010 | Publication without faculty affiliation
- Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel2009 | Third Faculty of Medicine
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial2012 | Publication without faculty affiliation
- Clopidogrel in 20102010 | First Faculty of Medicine
- Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents The Dual Antiplatelet Therapy Randomized Clinical Trial2015 | Publication without faculty affiliation
- Antiplatelet treatment of the ischemic heart disease2008 | Third Faculty of Medicine
- Therapy of Acute Myocardial Infarction in Unspecialised Medical Centres - Evaluation of Diagnostic and Therapeutic Practice2005 | Publication without faculty affiliation
- Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery2011 | Third Faculty of Medicine
- High-residual platelet activity despite dual antiplatelet treatment associated with subacute stent thrombosis2009 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Ticagrelor - first reversible inhibitor of ADP receptor P2Y122011 | Third Faculty of Medicine
- Survival After Solid Cancers in Antithrombotic Trials2015 | Second Faculty of Medicine
- Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery2010 | Third Faculty of Medicine
- Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)2014 | Third Faculty of Medicine
- Chapter 47: Percutaneous coronary interventions in patiens with acute coronary syndromes2015 | Third Faculty of Medicine